Howard Roesen
Foot Surgery · Newport News, VANPI 1790721223
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for foot surgery clinicians in VA, where the typical reported total is $1,143.
Across 50 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$182
- Convatec Inc.$180
- Paratek Pharmaceuticals, Inc.$145
- Smith+Nephew$100
- Kerecis Limited$84
- Bioventus LLC$83
- plus $354 from 12 others
What the payments were for
- Food & beverage$1,129100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 6 | $182 |
| Convatec Inc. | 7 | $180 |
| Paratek Pharmaceuticals, Inc. | 8 | $145 |
| Smith+Nephew | 4 | $100 |
| Kerecis Limited | 3 | $84 |
| Bioventus LLC | 4 | $83 |
| Organogenesis Inc. | 3 | $71 |
| Heron Therapeutics, Inc. | 2 | $53 |
| IBSA Pharma Inc. | 2 | $46 |
| Nabriva Therapeutics, PLC | 2 | $34 |
| Boston Scientific | 2 | $30 |
| AbbVie | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Dynasplint Systems Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $13 |
How this compares
$1,129 in reported general payments places this provider in the 45th percentile of 34 foot surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 105 | $2,208 |
| Diclofenac Sodium | 53 | $958 |
| Colchicine | 18 | $530 |
| Ammonium Lactate | 34 | $414 |
| Doxycycline Hyclate | 23 | $207 |
| Cephalexin | 29 | $174 |
| Terbinafine Hcl | 35 | $164 |
| Triamcinolone Acetonide | 28 | $117 |
| Prednisone | 21 | $62 |
| Meloxicam | 36 | $34 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Newport News
- Vickie DriverFairfax$177K
- Corine CreechFairfax$73K
- Srikanth MahavadiProvidence Forge$12K
- Kenneth WilhelmCentreville$8K
- Asif ShahGlen Allen$8K
- Michael ChungVirginia Beach$7K
- Soumaya BaderChesapeake$6K
- Marc BarbellaSuffolk$5K
- N Wynta WilliamsVirginia Beach$5K
- Noel PatelRichmond$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.